Chronic Spontaneous Urticaria Uncontrolled on Standard-Dose Antihistamine
A 41-year-old woman presents with a 9-month history of recurrent wheals on the trunk and arms, occurring 5 days per week and lasting 6–10 hours each. She has no angioedema, fever, weight loss, or joint pain. Cetirizine 10 mg daily reduces but does not control symptoms; her urticaria activity score over 7 days (UAS7) is 18. She has tried loratadine 10 mg daily and fexofenadine 180 mg daily without adequate control. Ibuprofen reliably triggers flares, so she avoids it. Physical examination is unremarkable except for scattered erythematous wheals. Complete blood count, erythrocyte sedimentation rate, and TSH are normal. She asks about stronger steroids, thyroid testing, and whether this will resolve. She is otherwise healthy and takes no other medications.
1. Outline the next three pharmacologic steps for this patient's chronic spontaneous urticaria, including doses and the rationale for avoiding systemic glucocorticoids as maintenance therapy.
Read the worked answer
Step 1 - Up-dose a second-generation antihistamine. The guideline-endorsed next step is to increase cetirizine to up to four times the standard dose (for example, 10 mg four times daily or 20 mg twice daily), which is off-label but supported by urticaria guidelines. Reassess after 2–4 weeks. The dose-dependent benefit is modest but avoids steroids.
Step 2 - Add omalizumab. If symptoms remain uncontrolled on up-dosed antihistamine, start omalizumab 300 mg subcutaneously every 4 weeks. It is effective in about two-thirds of patients with chronic spontaneous urticaria and has a favorable safety profile. Assess response after 12 weeks before considering it a failure.
Step 3 - Consider cyclosporine. For refractory disease, cyclosporine 2.5–5 mg/kg/day can be used with blood pressure, renal function, and drug-level monitoring. It is reserved for specialist use because of toxicity.
Why not maintenance glucocorticoids? Long-term prednisone causes osteoporosis, hyperglycemia, hypertension, cataracts, and adrenal suppression without modifying the disease course. A short course may be used for a severe exacerbation, but it is not a maintenance strategy. First-generation antihistamines at night are also avoided because of sedation and anticholinergic effects.
2. Which investigations are indicated in this patient, and which are not? Explain the role of thyroid autoantibodies and NSAID avoidance.
Read the worked answer
Indicated: The history and examination should guide testing. A complete blood count, inflammatory markers, and TSH are reasonable initial screens, and all are normal here. If symptoms change or systemic features appear, expand testing accordingly.
Not routinely indicated: Extensive autoimmunity panels, ANA, complement levels, food-specific IgE panels, and routine thyroid autoantibodies are not recommended in the absence of clinical clues. Thyroid autoantibodies are more common in chronic urticaria than in the general population, but their presence does not establish causation and does not usually change first-line management. They should be checked if there are symptoms or signs of thyroid disease, or in selected refractory cases.
NSAID avoidance: Avoid NSAIDs only when they reproducibly trigger wheals, as in this patient. She should use acetaminophen when an analgesic is needed. Blanket avoidance in all patients is unnecessary and can deprive patients of effective anti-inflammatory therapy.
Counseling: Explain that chronic spontaneous urticaria is not an allergy and is not contagious. About half of patients remit within 1 year, but some have disease for several years. Refer to a specialist if she remains uncontrolled on up-dosed antihistamines, develops angioedema with airway symptoms, or needs a biologic.
3. How would you counsel this patient about prognosis and when to seek urgent care?
Read the worked answer
Counsel that chronic spontaneous urticaria is usually self-limited but unpredictable. Roughly 50% of patients are symptom-free within 1 year, and a smaller proportion continue for more than 5 years. Treatment aims to control symptoms and maintain normal function, not to cure the disease.
She should continue daily antihistamines rather than taking them only on flare days, because daily dosing gives better control. Keep a symptom diary to assess response objectively.
Urgent review is needed for: tongue, lip, or throat swelling; difficulty breathing or swallowing; hoarseness; dizziness or syncope; or wheals that bruise or persist longer than 24 hours in a fixed location, which suggest urticarial vasculitis rather than chronic spontaneous urticaria.
She should also report new joint pain, fever, weight loss, or night sweats. These would prompt a broader workup. If she becomes pregnant, review antihistamine choice; loratadine and cetirizine are generally preferred, and omalizumab can be continued if needed under specialist guidance.